Thermo Fisher Scientific Extends Collaboration to Advance Biopharmaceutical Discovery and Development Kumar Jeetendra | October 30, 2020 SAN JOSE, Calif. – (October 29, 2020) – Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company, Servier, announce the extension of a strategic collaboration to deliver industry-proven, innovative characterization and quality control workflows for the simplified analysis of …
Automated Flow System takes the Drudgery Out of Reaction Optimisation Kumar Jeetendra | October 30, 2020 The FlowSyn Multi-X from Uniqsis takes the drudgery out of reaction optimisation – effortlessly converting your batch chemistry methods to more efficient, higher yielding flow chemistry protocols. Flow chemistry in microreactors offers many advantages over batch processing notably better reproducibility and scalability, improved yields and fewer problems with unstable intermediates or exothermic reactions. The FlowSyn …
HCG- The Specialist in Cancer Care in Collaboration with Pinkathon organized an awareness session on Women’s Health & Breast Cancer Kumar Jeetendra | October 30, 2020 Bangalore, 29th October 2020: To mark Breast Cancer awareness month observed in October, HCG-The Specialist in Cancer care in association with Pinkathon hosted The Pink Strong Talks, a virtual live session to create awareness on ‘women’s health and breast cancer’. The speakers for the session were Dr. BS Ajaikumar, Chairman & CEO, Healthcare Global Enterprise …
Bio-Gate successfully markets antiviral and antibacterial Protective Film Spray for surfaces Kumar Jeetendra | October 30, 2020 Nuremberg, 28. October 2020 – Bio-Gate AG (ISIN DE000BGAG981), one of the world’s leading suppliers of innovative technologies and individual solutions for health and hygiene, has successfully launched the new antiviral and antibacterial MSBG-Tec Protective Film Spray. The spray is being used in the public transport system in Nuremberg to supplement the existing hygiene measures. …
Johnson and Johnson intends to test its COVID-19 antibody in ages 12-18 soon Kumar Jeetendra | October 31, 2020 Based on safety and other things, the company intends to check in even younger children afterwards, said Sadoff, a vaccine research scientist in J&J’s Janssen unit, without giving a timeline. J&J said in a statement it is currently in discussions with partners and regulators concerning the addition of the pediatric population in its trials. The …
CN Bio declares dispatch of medication digestion and wellbeing poisonousness testing administrations Kumar Jeetendra | October 31, 2020 Liver toxicity is a principal safety concern during drug discovery and development, with the potential to terminate expensive clinical trials already underway. The new services will incorporate the Company’s advanced Liver-on-Chip technology and experience in the field to enable researchers to create predictive and human-relevant data, improving the translatability from discovery to clinic, and hastening …
SARS-CoV-2 hereditary changes may have made COVID-19 more infectious Kumar Jeetendra | October 31, 2020 A study involving over 5,000 COVID-19 patients in Houston finds the virus which causes the disease is accumulating genetic mutations, one of which may have made it longer infectious. According to the paper published in the peer reviewed journal mBIO, that mutation, known as D614G, is found in the spike protein that pries open our …
Bharat Biotech to dispatch Covaxin in Q2 2021 Kumar Jeetendra | November 1, 2020 Bharat Biotech is planning to establish its own vaccine for COVID-19 in the second quarter next year when it will get the requisite approvals in the Indian regulatory authorities, a top company official said. It stated its immediate focus is to conduct the Phase 3 trials across websites in the nation. The company’s vaccine candidate …
Drug used to control pulse may improve malignant growth patients’ reaction to immunotherapy Kumar Jeetendra | November 1, 2020 The exact same biochemical triggers which spur a”flight or fight” reaction once we encounter threats may help tumor cells to thrive. A group of researchers from Roswell Park Comprehensive Cancer Center is looking at ways to interrupt that dynamic so that cancer therapies can be effective. Their latest work, published today in Clinical Cancer Research, …
CureVac’s COVID-19 antibody triggers invulnerable reaction in Phase I preliminary Kumar Jeetendra | November 2, 2020 CureVac’s experimental COVID-19 vaccine triggered an immune response in humans, it said on Monday, placing the German biotech firm on track to start mass testing this year since the race to end the pandemic heats up. “We are very encouraged by the interim Phase I data,” Chief Executive Officer Franz-Werner Haas said in a statement, …
Washing hands and Halloween candy can diminish COVID-19 introduction hazard Kumar Jeetendra | November 2, 2020 New research indicates that COVID-19 exposure risk from contaminated candy might be successfully mitigated either by washing hands and washing candy with a simple at-home technique. A group of researchers published this work today in mSystems, an open-access journal of the American Society for Microbiology. The researchers enrolled 10 recently diagnosed asymptomatic or mildly/moderately symptomatic …
Gilson Customized low-cost automated tube filling system – ideal for VTM Kumar Jeetendra | November 2, 2020 With the current pandemic, there is an exponential demand for diagnostic testing of patients for COVID-19, the disease caused by the SARS-CoV-2 virus. Viral transport media (VTM) is a critical component of COVID-19 test kits and is used for the collection, transport, and storage of clinical specimens. As companies and laboratories accelerate the manufacturing of …
